Assignee
IL DONG PHARMA
KR·8 granted patents·7 pending applications·67 citations·filing 1993–2024
Top patents by PatentIndex Score
15 records- 0179US11225472B2Phenyl propionic acid derivatives and uses thereofIL DONG PHARMA·Filed 2017·Granted Jan 18, 2022·2 cites·17 claims
- 0277US11268064B2Lactobacillus rhamnosus RHT-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseasesIL DONG PHARMA·Filed 2019·Granted Mar 8, 2022·0 cites·13 claims
- 0375US2024262799A1Isoxazole derivatives as nuclear receptor agonists and uses thereofIL DONG PHARMA·Filed 2024·Application pending·0 cites
- 0472US10919947B2Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2018·Granted Feb 16, 2021·1 cites·10 claims
- 0572US5527832AAntiinflammatory and analgesic transdermal gelIL DONG PHARMA·Filed 1994·Granted Jun 18, 1996·59 cites·2 claims
- 0667US10443033B2Lactobacillus rhamnosus RHT-3201 (KCTC 10833BP) conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseasesIL DONG PHARMA·Filed 2016·Granted Oct 15, 2019·0 cites·8 claims
- 0765US2023285474A1Novel bifidobacterium breve idcc 4401 strain and its dead cell id-bbr4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemiaIL DONG PHARMA·Filed 2022·Application pending·0 cites
- 0858US10988449B2Isoxazole derivatives as nuclear receptor agonists and uses thereofIL DONG PHARMA·Filed 2018·Granted Apr 27, 2021·0 cites·12 claims
- 0953US2024009254A1Composition for preventing or treating periodontal diseases, comprising bacillus velezensis strain, culture medium thereof, or culture supernatant thereof as active ingredientIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 1053US2023381093A1Bacillus subtilis strain and use thereofIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 1153US2023372414A1Novel bacillus velezensis strains and uses thereofIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 1251US2022409677A1Novel probiotic composition for regulation of intestinal immunityIL DONG PHARMA·Filed 2019·Application pending·0 cites
- 1351US2021253657A1Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and antiangiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 1442US6063778ACephalosporin derivatives and processes for the preparation thereofIL DONG PHARMA·Filed 1996·Granted May 16, 2000·3 cites·4 claims
- 1536US5663331ACephalosporin compoundsIL DONG PHARMA·Filed 1993·Granted Sep 2, 1997·2 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when IL DONG PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →